Clinical Trial Update: Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a single-infusion regimen of liposomal amphotericin B for visceral leishmaniasis in India has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)

Snippet

Sponsor: Banaras Hindu University | Conditions: Visceral Leishmaniasis | Phase 3 | Status: COMPLETED